All Keywords
Are Anti-Receptor-Binding Domain Antibodies Still a Relevant Proxy for Monitoring SARS-CoV-2 Neutralizing Activity in the Omicron Era?
[Category] COVID19(2023년),
[Source] pubmed
Communicable Diseases Research
감염병 연구데이터